BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 31154723)

  • 1. [Influence of Toll-like receptor 7 on CD8(+) T lymphocytes in patients with breast cancer].
    Qin S; Dong LP; Bai B; Xue HC
    Zhonghua Yi Xue Za Zhi; 2019 May; 99(20):1562-1566. PubMed ID: 31154723
    [No Abstract]   [Full Text] [Related]  

  • 2. [The regulatory function of tumor-infiltrating Th9 cells to anti-tumor activity of CD8(+) T cells in patients with gastric cancer].
    Sun PS; Gao ZJ; Fan LX; Liu YF; Chen BH; Mu SZ; Yan ZQ
    Zhonghua Zhong Liu Za Zhi; 2022 Nov; 44(11):1186-1193. PubMed ID: 36380667
    [No Abstract]   [Full Text] [Related]  

  • 3. [The modulatory activity of T cell immunoglobulin and mucin domain-containing protein 3 on T lymphocytes in patients with chronic heart failure].
    Yu HW; Dong YY; Dang YH
    Zhonghua Yi Xue Za Zhi; 2020 May; 100(17):1315-1319. PubMed ID: 32375439
    [No Abstract]   [Full Text] [Related]  

  • 4. Notch signaling pathway suppresses CD8
    Li S; Wang Z; Li XJ
    Int Immunopharmacol; 2018 Oct; 63():129-136. PubMed ID: 30086535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Increased Notch receptors induces CD8(+) T cell exhaustion in patients with prostate cancer].
    Wang RX; Li YF; Hao CH; Fang W
    Zhonghua Yi Xue Za Zhi; 2020 Sep; 100(34):2669-2674. PubMed ID: 32921015
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of interleukin-7 on the anti-tumor function of CD8(+) T cells in patients with non-small cell lung cancer].
    Zhang XH; Wang HM; Jin L; Chang R; Zu FC; Li FZ; Ku CY
    Zhonghua Yi Xue Za Zhi; 2018 Aug; 98(30):2429-2433. PubMed ID: 30138989
    [No Abstract]   [Full Text] [Related]  

  • 7. Activation of Toll-like receptor 2 enhances peripheral and tumor-infiltrating CD8
    Xu J; Guo R; Jia J; He Y; He S
    BMC Immunol; 2021 Oct; 22(1):67. PubMed ID: 34620075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytolytic effector mechanisms and gene expression in autologous graft-versus-host disease: distinct roles of perforin and Fas ligand.
    Miura Y; Thoburn CJ; Bright EC; Hess AD
    Biol Blood Marrow Transplant; 2004 Mar; 10(3):156-70. PubMed ID: 14993881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of TLR7 in CD8(+) T cells leads to TLR7-mediated activation and accessory cell-dependent IFN-gamma production in HIV type 1 infection.
    Song Y; Zhuang Y; Zhai S; Huang D; Zhang Y; Kang W; Li X; Liu Q; Yu Q; Sun Y
    AIDS Res Hum Retroviruses; 2009 Dec; 25(12):1287-95. PubMed ID: 19954299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical significance of ascitic interleukin-7 expression levels in cirrhotic patients complicated with spontaneous bacterial peritonitis].
    Hou HR; Pan HH; Li YK; Wei JF; Kang YH; Mao CS; Shang J; Kang Y
    Zhonghua Gan Zang Bing Za Zhi; 2019 Apr; 27(4):274-280. PubMed ID: 31082338
    [No Abstract]   [Full Text] [Related]  

  • 11. Impaired CD8(+) T cell responses upon Toll-like receptor activation in common variable immunodeficiency.
    de Lollo C; de Moraes Vasconcelos D; da Silva Oliveira LM; de Oliveira Titz T; Carneiro-Sampaio M; Jacob CM; da Silva Duarte AJ; Sato MN
    J Transl Med; 2016 May; 14(1):138. PubMed ID: 27188997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-Like Receptor 7 Agonist GS-9620 Induces HIV Expression and HIV-Specific Immunity in Cells from HIV-Infected Individuals on Suppressive Antiretroviral Therapy.
    Tsai A; Irrinki A; Kaur J; Cihlar T; Kukolj G; Sloan DD; Murry JP
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28179531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A conjugate of octamer-binding transcription factor 4 and toll-like receptor 7 agonist prevents the growth and metastasis of testis embryonic carcinoma.
    Lin G; Wang X; Yi W; Zhang C; Xu G; Zhu X; Cai Z; Liu Y; Diao Y; Lin MC; Jin G
    J Transl Med; 2015 May; 13():166. PubMed ID: 25990580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclosporine and tacrolimus have inhibitory effects on toll-like receptor signaling after liver transplantation.
    Howell J; Sawhney R; Testro A; Skinner N; Gow P; Angus P; Ratnam D; Visvanathan K
    Liver Transpl; 2013 Oct; 19(10):1099-107. PubMed ID: 23894100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dysfunctional innate immune response triggered by Toll-like receptor activation is restored by TLR7/TLR8 and TLR9 ligands in cutaneous lichen planus.
    Domingues R; de Carvalho GC; da Silva Oliveira LM; Futata Taniguchi E; Zimbres JM; Aoki V; da Silva Duarte AJ; Sato MN
    Br J Dermatol; 2015 Jan; 172(1):48-55. PubMed ID: 24976336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toll-like receptor-7 activation in CD8+ T cells modulates inflammatory mediators in patients with rheumatoid arthritis.
    Swain N; Tripathy A; Padhan P; Raghav SK; Gupta B
    Rheumatol Int; 2022 Jul; 42(7):1235-1245. PubMed ID: 35142867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression and clinical significance of CCL5 in patients with esophageal carcinoma].
    Liu J; Li F; Chen X; Wang L; Yue D; Zhao S; Hu W; Kalinski P; Thorne S; Hou J; Zhang Y
    Zhonghua Zhong Liu Za Zhi; 2014 Nov; 36(11):828-33. PubMed ID: 25620479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toll-Like Receptor 7 Activation Enhances CD8+ T Cell Effector Functions by Promoting Cellular Glycolysis.
    Li Q; Yan Y; Liu J; Huang X; Zhang X; Kirschning C; Xu HC; Lang PA; Dittmer U; Zhang E; Lu M
    Front Immunol; 2019; 10():2191. PubMed ID: 31572396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Modulation of TLR9 on anti-tumor immune responses of peripheral blood mononuclear cells from patients with non-small-cell lung cancer].
    Ren T; Cai YY; Liang YJ; Jin ML; Guo ZL; Tao MF; He X
    Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(17):1168-72. PubMed ID: 18844109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A clonal culture system demonstrates that IL-4 induces a subpopulation of noncytolytic T cells with low CD8, perforin, and granzyme expression.
    Kienzle N; Buttigieg K; Groves P; Kawula T; Kelso A
    J Immunol; 2002 Feb; 168(4):1672-81. PubMed ID: 11823496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.